SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Morrow JJ, Graig JJ. Anti-epileptic drugs in pregnancy: current safety and other issues. Exp Opin Pharmacother 2003;4: 445456.
  • 2
    Yerby M. Treatment of epilepsy during pregnancy. In: WyllieE, ed. The Treatment of Epilepsy: Principles and Practice. Baltimore : Williams & Wilkins, 1996: 785798.
  • 3
    Meador KJ, Zupang ML. Neurodevelopmental outcomes of children born to mothers with epilepsy. Cleve Clin J Med 2004;71(suppl 2):S38S41.
  • 4
    Kaneko S, Battino D, Andermann E, et al. Congenital malformations due to antiepileptic drugs. Epilepsy Res 1999;33: 145158.
  • 5
    Holmes LB, Harvey EA, Coull BA, et al. The teratogenicity of anticonvulsant drugs. N Engl J Med 2001;344: 11321138.
  • 6
    Polifka JE, Friedman JM. Medical genetics, 1: clinical teratology in the age of genomics. CMAJ 2002;167: 265273.
  • 7
    Delgado-Escueta AV, Janz D. Consensus guidelines: preconception counseling, management and care of the pregnant woman with epilepsy. Neurology 1992;42(suppl 5):149160.
  • 8
    Commission on Genetics, Pregnancy, and the Child: International League Against Epilepsy. Guidelines for the care of women of childbearing age with epilepsy. Epilepsia 1993;34: 588589.
  • 9
    Committee on Educational Bulletins of the American College of Obstetricians and Gynecologists. Seizure disorders in pregnancy. Int J Gynecol Obstet 1997;56: 279286.
  • 10
    Tomson T, Gram L, Sillanpää M, et al. Recommendations for the management and care of pregnant women with epilepsy. In: TomsonT, GramL, SillanpääM, JohannessenS. eds., Epilepsy and pregnancy. Guilford : Wrightson Biomedical Publishing, 1997: 201208.
  • 11
    Wallace H, Shorvon SD, Hopkins A, et al. Adults with poorly controlled epilepsy. London : Royal College of Physicians , 1997.
  • 12
    American Academy of Neurology. Practice Parameter: management issues for women with epilepsy (summary statement): report of the quality standards subcommittee. Neurology 1998;51: 944948.
  • 13
    Crawford P, Appleton R, Betts T, et al. Best practice guidelines for the management of women with epilepsy. Seizure 1999;8: 201217.
  • 14
    Gaily E, Kantola-Sorsa E, Hiilesmaa V, et al. Normal intelligence in children with prenatal exposure to carbamazepine. Neurology 2004;62: 2832.
  • 15
    Seale CG, Morrell MJ, Nelson L, et al. Analysis of prenatal and gestational care given to women with epilepsy. Neurology 1998;51: 10391045.
  • 16
    Fairgrieve SD, Jackson M, Jonas P, et al. Population based, prospective study of the care of women with epilepsy in pregnancy. BMJ 2000;321: 674675.
  • 17
    Engel J Jr, International League Against Epilepsy (ILAE) . A proposed diagnostic scheme for people with epileptic seizures and with epilepsy: report of the ILAE Task Force on Classification and Terminology. Epilepsia 2001;42: 796803.
  • 18
    Nelson K, Holmes LB. Malformations due to presumed spontaneous mutation in newborn infants. N Engl J Med 1989;320: 1923.
  • 19
    Tomson T, Battino D, Bonizzoni E, et al., on behalf of the collaborative EURAP study group. EURAP: an international registry of antiepileptic drugs and pregnancy. Epilepsia 2004;45: 14631464.
  • 20
    Russell AJC, Craig JJ, Morrison P, et al. UK epilepsy and pregnancy group. Epilepsia 2004;45: 1467.
  • 21
    Holmes LB, Wyszynski DF. North American Antiepileptic Drug Pregnancy Registry. Epilepsia 2004;45: 1465.
  • 22
    Vajda F, Lander C, O'Brien T, et al. Australian Pregnancy Registry of Women Taking Antiepileptic Drugs. Epilepsia 2004;45: 1466.
  • 23
    Hiilesmaa VK, Bardy A, Teramo K. Obstetric outcome in women with epilepsy. Am J Obstet Gynecol 1985;152: 499504.
  • 24
    Wide K, Winbladh B, Tomson T, et al. Body dimensions of infants exposed to antiepileptic drugs in utero: observations spanning 25 years. Epilepsia 2000;41: 854861.
  • 25
    Battino D, Kaneko S, Andermann E, et al. Intrauterine growth in the offspring of epileptic women: a prospective multicenter study. Epilepsy Res 1999;36: 5360.
  • 26
    Thorp JA, Gaston L, Caspers DR, et al. Current concepts and controversies in the use of vitamin K. Drugs 1995;49: 376387.
  • 27
    Cornelissen M, Steegers-Theunissen R, Kollee L, et al. Supplementation of vitamin K in pregnant women receiving anticonvulsant therapy prevents neonatal vitamin K deficiency. Am J Obstet Gynecol 1993;168: 884888.
  • 28
    Tettenborn B, Genton P, Polson D. Epilepsy and women's issues: an update. Epileptic Disord 2002;4(suppl 2):S23S31.
  • 29
    Kaaja E, Kaaja R, Matila R, et al. Enzyme-inducing antiepileptic drugs in pregnancy and the risk of bleeding in the neonate. Neurology 2002;58: 549553.
  • 30
    Sabers A, ARogvni-Hansen B, Dam M, et al. Pregnancy and epilepsy: a retrospective study of 151 pregnancies. Acta Neurol Scand 1998;97: 164170.
  • 31
    Adab N, Jacoby A, Smith D, et al. Additional needs in children born to mothers with epilepsy. J Neurol Neurosurg Psychiatry 2001;70: 1521.
  • 32
    Gaily E, Kantola-Sorsa E, Granström M-L. Specific cognitive dysfunction in children with epileptic mothers. Dev Med Child Neurol 1990;32: 403414.
  • 33
    Scolnik D, Nulman I, Rovet J, et al. Neurodevelopment of children exposed in utero to phenytoin and carbamazepine monotherapy. JAMA 1994;271: 767770.